Go-Dact: A Phase 3b Randomized Double-Blind Placebo-Controled Proof-Of-Concept Trial, of Golimumab Plus Methotrexate (MTX) versus MTX Monotherapy, in Improving Dactylitis, in MTX Naive Psoriatic Arthritis Patients
ARTHRITIS & RHEUMATOLOGY（2019）
关键词
golimumab plus methotrexate,mtx monotherapy,improving dactylitis,arthritis,go-dact,double-blind,placebo-controled,proof-of-concept
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要